Dengue Vaccine Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product (CYD-TDV); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Others) and Geography
Dengue is a vector-borne disease caused due to virus that belongs to the Flaviviridae family and genus Flavivirus. Dengue fever is developed to a person who is bitten by infected Aedes aegypti mosquito. The symptoms of dengue disease include fever, headache, fatigue, muscle pain, diarrhea, anemia, skin rashes, and vomiting.
The dengue vaccine market is anticipated to grow in the forecast, owing to the factors such as increasing prevalence of the diseases, large unmet medical need for managing dengue burden, promising end stage vaccine, adoption of dengue vaccines by several countries, and promising end stage vaccine pipeline. Nevertheless, cold chain systems for storage of vaccine in resource constrained countries is expected to hamper the market growth during the forecast period.
The "Global Dengue Vaccine Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of dengue vaccine market with detailed market segmentation by product, distribution channel and geography. The global dengue vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading dengue vaccine market players and offers key trends and opportunities in the market.
The global market is segmented on the basis of product and distribution channel. Based on product the market is segmented into CYD-TDV. Based on distribution channel the market is segmented into hospitals pharmacies, retail pharmacies, drug stores, online pharmacies, and others.
Get more information on this report :
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global dengue vaccine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The dengue vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting dengue vaccine market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Dengue Vaccine market in these regions.
Get more information on this report :
The reports cover key developments in the dengue vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from dengue vaccine market are anticipated to lucrative growth opportunities in the future with the rising demand for dengue vaccine market in the global market. Below mentioned is the list of few companies engaged in the dengue vaccine market.
The report also includes the profiles of dengue vaccine market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Sanofi Pasteur Limited
Takeda Pharmaceutical Company Limited
Merck Sharp & Dohme Corp
GeneOne Life Science
Medigen Vaccine Biologics
Panacea Biotec Limited
Sun Pharmaceutical Industries Ltd
Serum Institute of India Pvt. Ltd
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.